These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

542 related articles for article (PubMed ID: 29471391)

  • 1. Comparative efficacy of enrofloxacin to that of tulathromycin for the control of bovine respiratory disease and prevalence of antimicrobial resistance in Mannheimia haemolytica in calves at high risk of developing bovine respiratory disease.
    Crosby S; Credille B; Giguère S; Berghaus R
    J Anim Sci; 2018 Apr; 96(4):1259-1267. PubMed ID: 29471391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidrug resistant Mannheimia haemolytica isolated from high-risk beef stocker cattle after antimicrobial metaphylaxis and treatment for bovine respiratory disease.
    Woolums AR; Karisch BB; Frye JG; Epperson W; Smith DR; Blanton J; Austin F; Kaplan R; Hiott L; Woodley T; Gupta SK; Jackson CR; McClelland M
    Vet Microbiol; 2018 Jul; 221():143-152. PubMed ID: 29981701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of multi drug antimicrobial resistance in isolated from high-risk stocker cattle at arrival and two weeks after processing.
    Snyder E; Credille B; Berghaus R; Giguère S
    J Anim Sci; 2017 Mar; 95(3):1124-1131. PubMed ID: 28380515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and antimicrobial susceptibility of Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni isolated from the lower respiratory tract of healthy feedlot cattle and those diagnosed with bovine respiratory disease.
    Timsit E; Hallewell J; Booker C; Tison N; Amat S; Alexander TW
    Vet Microbiol; 2017 Sep; 208():118-125. PubMed ID: 28888626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limitations of bacterial culture, viral PCR, and tulathromycin susceptibility from upper respiratory tract samples in predicting clinical outcome of tulathromycin control or treatment of bovine respiratory disease in high-risk feeder heifers.
    Sarchet JJ; Pollreisz JP; Bechtol DT; Blanding MR; Saltman RL; Taube PC
    PLoS One; 2022; 17(2):e0247213. PubMed ID: 35143504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between antimicrobial drug class for treatment and retreatment of bovine respiratory disease (BRD) and frequency of resistant BRD pathogen isolation from veterinary diagnostic laboratory samples.
    Coetzee JF; Magstadt DR; Sidhu PK; Follett L; Schuler AM; Krull AC; Cooper VL; Engelken TJ; Kleinhenz MD; O'Connor AM
    PLoS One; 2019; 14(12):e0219104. PubMed ID: 31835273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative minimum inhibitory and mutant prevention drug concentrations of enrofloxacin, ceftiofur, florfenicol, tilmicosin and tulathromycin against bovine clinical isolates of Mannheimia haemolytica.
    Blondeau JM; Borsos S; Blondeau LD; Blondeau BJ; Hesje CE
    Vet Microbiol; 2012 Nov; 160(1-2):85-90. PubMed ID: 22677482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial Metaphylaxis and its Impact on Health, Performance, Antimicrobial Resistance, and Contextual Antimicrobial Use in High-Risk Beef Stocker Calves.
    Credille B; Berghaus RD; Jane Miller E; Credille A; Schrag NFD; Naikare H
    J Anim Sci; 2024 Jan; 102():. PubMed ID: 38126883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial resistance in
    Credille B
    Anim Health Res Rev; 2020 Dec; 21(2):196-199. PubMed ID: 33261715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic characterization of susceptible and multi-drug resistant Mannheimia haemolytica isolated from high-risk stocker calves prior to and after antimicrobial metaphylaxis.
    Snyder ER; Alvarez-Narvaez S; Credille BC
    Vet Microbiol; 2019 Aug; 235():110-117. PubMed ID: 31282368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bactericidal effects of various concentrations of enrofloxacin, florfenicol, tilmicosin phosphate, and tulathromycin on clinical isolates of Mannheimia haemolytica.
    Blondeau JM; Shebelski SD; Hesje CK
    Am J Vet Res; 2015 Oct; 76(10):860-8. PubMed ID: 26413823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and temporal trends in antimicrobial resistance of bovine respiratory disease pathogen isolates submitted to the Wisconsin Veterinary Diagnostic Laboratory: 2008-2017.
    Holschbach CL; Aulik N; Poulsen K; Ollivett TL
    J Dairy Sci; 2020 Oct; 103(10):9464-9472. PubMed ID: 32747101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tulathromycin metaphylaxis increases nasopharyngeal isolation of multidrug resistant
    Crosby WB; Karisch BB; Hiott LM; Pinnell LJ; Pittman A; Frye JG; Jackson CR; Loy JD; Epperson WB; Blanton J; Capik SF; Morley PS; Woolums AR
    Front Vet Sci; 2023; 10():1256997. PubMed ID: 38053814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal effects of enrofloxacin or tulathromycin use in preweaned calves at high risk of bovine respiratory disease on the shedding of antimicrobial-resistant fecal Escherichia coli.
    Pereira RV; Altier C; Siler JD; Mann S; Jordan D; Warnick LD
    J Dairy Sci; 2020 Nov; 103(11):10547-10559. PubMed ID: 32861496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotypic antimicrobial resistance characterization of E. coli from dairy calves at high risk of respiratory disease administered enrofloxacin or tulathromycin.
    Pereira RV; Foditsch C; Siler JD; Dulièpre SC; Altier C; Garzon A; Warnick LD
    Sci Rep; 2020 Nov; 10(1):19327. PubMed ID: 33168881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activities of tulathromycin and ceftiofur combined with other antimicrobial agents using bovine Pasteurella multocida and Mannheimia haemolytica isolates.
    Sweeney MT; Brumbaugh GW; Watts JL
    Vet Ther; 2008; 9(3):212-22. PubMed ID: 19003782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative efficacy of tilmicosin versus tulathromycin as a metaphylactic antimicrobial in feedlot calves at moderate risk for respiratory disease.
    Van Donkersgoed J; Merrill J; Hendrick S
    Vet Ther; 2008; 9(4):291-7. PubMed ID: 19177334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of Bacterial Therapeutics against the Bovine Respiratory Pathogen Mannheimia haemolytica.
    Amat S; Timsit E; Baines D; Yanke J; Alexander TW
    Appl Environ Microbiol; 2019 Nov; 85(21):. PubMed ID: 31444198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating the comparative clinical and economic consequences of tulathromycin for treatment of present or anticipated outbreaks of bovine respiratory disease in feedlot cattle in the United States.
    Nautrup BP; Van Vlaenderen I; Gasper SM; Holland RE
    J Anim Sci; 2013 Dec; 91(12):5868-77. PubMed ID: 24126273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotyping and antimicrobial resistance of Mannheimia haemolytica strains from European cattle with bovine respiratory disease.
    Andrés-Lasheras S; Zaheer R; Klima C; Sanderson H; Ortega Polo R; Milani MRM; Vertenten G; McAllister TA
    Res Vet Sci; 2019 Jun; 124():10-12. PubMed ID: 30776549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.